|
"liou jing ping"的相關文件
顯示項目 11-35 / 54 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2016 |
LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo
|
Huang, Han-Li; Chao, Min-Wu; Chen, Chung-Chun; Cheng, Chun-Chun; Chen, Mei-Chuan; Lin, Chao-Feng; Liou, Jing-Ping; Teng, Che-Ming; Pan, Shiow-Lin; 鄧哲明; 陳青周 |
| 國立臺灣大學 |
2016 |
MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancer
|
Huang, Han-Li; Chao, Min-Wu; Li, Ya-Chi; Chang, Li-Hsun; Chen, Chun-Han; Chen, Mei-Chuan; Cheng, Chun-Chun; Liou, Jing-Ping; Teng, Che-Ming; Pan, Shiow-Lin; 鄧哲明 |
| 國立臺灣大學 |
2016 |
2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase
|
Lee, Hsueh-Yun; Chang, Chih-Yi; Su, Chih-Jou; Huang, Han-Li; Mehndiratta, Samir; Chao, Yuh-Hsuan; Hsu, Chia-Ming; Kumar, Sunil; Sung, Ting-Yi; Huang, Yi-Zhen; Li, Yu-Hsuan; Yang, Chia-Ron; Liou, Jing-Ping; 楊家榮 |
| 國立成功大學 |
2015-08-01 |
Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes
|
Lee, Hsueh-Yun; Chang, Chih-Yi; Lai, Mei-Jung; Chuang, Hsun-Yueh; Kuo, Ching-Chuan; Chang, Chi-Yen; Chang, Jang-Yang; Liou, Jing-Ping |
| 衛生福利部國家中醫藥研究所 |
2015 |
MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27
|
Pai, Hui Chen; Kumar, Sunil; Shen, Chien-Chang; Liou, Jing Ping; Pan, Shiow Lin; Teng, Che Ming |
| 國立臺灣大學 |
2015 |
Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo
|
Huang, Han-Li; Peng, Chieh-Yu; Lai, Mei-Jung; Chen, Chun-Han; Lee, Hsueh-Yun; Wang, Jing-Chi; Liou, Jing-Ping; Pan, Shiow-Lin; Teng, Che-Ming; 鄧哲明 |
| 國立臺灣大學 |
2015 |
MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27
|
Pai, Hui Chen; Kumar, Sunil; Shen, Chien Chang; Liou, Jing Ping; Pan, Shiow Lin; Teng, Che Ming; 鄧哲明 |
| 國立臺灣大學 |
2015 |
The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo
|
Chao, Min-Wu; Lai, Mei-Jung; Liou, Jing-Ping; Chang, Ya-Ling; Wang, Jing-Chi; Pan, Shiow-Lin; Teng, Che-Ming; 張雅玲; 鄧哲明 |
| 國立臺灣大學 |
2015 |
N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling
|
Lai, Mei-Jung; Lee, Hsueh-Yun; Chuang, Hsun-Yueh; Chang, Li-Hsun; Tsai, An-Chi; Chen, Mei-Chuan; Huang, Han-Lin; Wu, Yi-Wen; Teng, Che-Ming; Pan, Shiow-Lin; Liu, Yi-Min; Mehndiratta, Samir; Liou, Jing-Ping; 鄧哲明 |
| 國立臺灣大學 |
2015 |
Molecular mechanisms underlying the antitumor activity of (E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin- 6-yl)acrylamide in human colorectal cancer cells in vitro and in vivo
|
Chen, Chun-Han; Lee, Chia-Hwa; Liou, Jing-Ping; Teng, Che-Ming; Pan, Shiow-Lin; 鄧哲明 |
| 國立臺灣大學 |
2015 |
Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesis
|
Huang, Yen-Chia; Huang, Fang-I; Mehndiratta, Samir; Lai, Ssu-Chia; Liou, Jing-Ping; Yang, Chia-Ron; 楊家榮 |
| 國立成功大學 |
2014-09-01 |
Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents
|
Mehndiratta, Samir; Chiang, Yi-Fang; Lai, Mei-Jung; Lee, Hsueh-Yun; Chen, Mei-Chuan; Kuo, Ching-Chuan; Chang, Chi-Yen; Chang, Jang-Yang; Liou, Jing-Ping |
| 國立成功大學 |
2014-05-22 |
Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells
|
Lee, Hsueh-Yun; Tsai, An-Chi; Chen, Mei-Chuan; Shen, Po-Jung; Cheng, Yun-Ching; Kuo, Ching-Chuan; Pan, Shiow-Lin; Liu, Yi-Min; Liu, Jin-Fen; Yeh, Teng-Kuang; Wang, Jing-Chi; Chang, Chi-Yen; Chang, Jang-Yang; Liou, Jing-Ping |
| 國立成功大學 |
2014-04 |
Antimitotic and vascular disrupting agents: 2-Hydroxy-3,4,5-trimethoxybenzophenones
|
Chang, Chih-Yi; Chuang, Hsun-Yueh; Lee, Hsueh-Yun; Yeh, Teng-Kuang; Kuo, Ching-Chuan; Chang, Chi-Yen; Chang, Jang-Yang; Liou, Jing-Ping |
| 臺北醫學大學 |
2014 |
Curcumin Suppress Cardiac Fibroblasts Activities by Regulating Proliferation, Migration, and the Extracellular Matrix
|
Chung, Cheng-Chih;Kao, Yu-Hsun;Liou, Jing-Ping;Chen, Yi-Jen |
| 臺北醫學大學 |
2014 |
Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-beta and angiotensin II signaling
|
Chung, Cheng-Chih;Hsu, Rung-Chieh;Kao, Yu-Hsun;Liou, Jing-Ping;Lu, Yen-Yu;Chen, Yi-Jen |
| 臺北醫學大學 |
2014 |
Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity
|
Mehndiratta, Samir;Hsieh, Yi-Ling;Liu, Yi-Min;Wang, Amber Weiching;Lee, Hsueh-Yun;Liang, Lung-Yu;Kumar, Sunil;Teng, Che-Ming;Yang, Chia-Ron;Liou, Jing-Ping |
| 臺北醫學大學 |
2014 |
Denbinobin upregulates miR-146a expression and attenuates IL-1 beta-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytes
|
Yang, Chia-Ron;Shih, Kao-Shang;Liou, Jing-Ping;Wu, Yi-Wen;Hsieh, I-Ni;Lee, Hsueh-Yun;Lin, Tzu-Cheng;Wang, Jyh-Horng |
| 臺北醫學大學 |
2014 |
Antimitotic and vascular disrupting agents: 2-Hydroxy-3,4,5-trimethoxybenzophenones
|
Chang, Chih-Yi;Chuang, Hsun-Yueh;Lee, Hsueh-Yun;Yeh, Teng-Kuang;Kuo, Ching-Chuan;Chang, Chi-Yen;Chang, Jang-Yang;Liou, Jing-Ping |
| 臺北醫學大學 |
2014 |
Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1 alpha by Inhibiting Prolyl-4-Hydroxylase PHD2
|
Hou, Peifeng;Kuo, Ching-Ying;Cheng, Chun-Ting;Liou, Jing-Ping;Ann, David K.;Chen, Qiang |
| 臺北醫學大學 |
2014 |
Tubulin inhibitors: a patent review
|
Liu, Yi-Min;Chen, Hsiao-Ling;Lee, Hsueh-Yun;Liou, Jing-Ping |
| 臺北醫學大學 |
2014 |
Effect of C7-substitution of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines on the selectivity towards a subclass of histone deacetylases
|
Lee, Hsueh-Yun;Wang, Li-Ting;Li, Yu-Hsuan;Pan, Shiow-Lin;Chen, Yi-Lin;Teng, Che-Ming;Liou, Jing-Ping |
| 臺北醫學大學 |
2014 |
In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
Tsai, An-Chi;Pai, Hui-Chen;Wang, Chih-Ya;Liou, Jing-Ping;Teng, Che-Ming;Wang, Jing-Chi;Pan, Shiow-Lin |
| 臺北醫學大學 |
2014 |
A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKC delta and E-cadherin
|
Wang, Li-Ting;Liou, Jing-Ping;Li, Yu-Hsuan;Liu, Yi-Min;Pan, Shiow-Lin;Teng, Che-Ming |
| 國立臺灣大學 |
2014 |
Synergistic Interaction between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer Cells In Vitro and In Vivo
|
Chen, Chun-Han; Chen, Mei-Chuan; Wang, Jing-Chi; Tsai, An-Chi; Chen, Ching-Shih; Liou, Jing-Ping; Pan, Shiow-Lin; Teng, Che-Ming; 鄧哲明 |
顯示項目 11-35 / 54 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
